Finegold MJ - Search Results

1

Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo.

Paulk NK, Wursthorn K, Wang Z, Finegold MJ, Kay MA, Grompe M. Paulk NK, et al. Among authors: finegold mj. Hepatology. 2010 Apr;51(4):1200-8. doi: 10.1002/hep.23481. Hepatology. 2010. PMID: 20162619 Free PMC article.

2

Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer.

Hickey RD, Lillegard JB, Fisher JE, McKenzie TJ, Hofherr SE, Finegold MJ, Nyberg SL, Grompe M. Hickey RD, et al. Among authors: finegold mj. Hepatology. 2011 Oct;54(4):1351-9. doi: 10.1002/hep.24490. Epub 2011 Aug 9. Hepatology. 2011. PMID: 21674562 Free PMC article.

3

AAV-mediated gene targeting is significantly enhanced by transient inhibition of nonhomologous end joining or the proteasome in vivo.

Paulk NK, Loza LM, Finegold MJ, Grompe M. Paulk NK, et al. Among authors: finegold mj. Hum Gene Ther. 2012 Jun;23(6):658-65. doi: 10.1089/hum.2012.038. Epub 2012 Jun 25. Hum Gene Ther. 2012. PMID: 22486314 Free PMC article.

4

AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence.

Wang Z, Lisowski L, Finegold MJ, Nakai H, Kay MA, Grompe M. Wang Z, et al. Among authors: finegold mj. Mol Ther. 2012 Oct;20(10):1902-11. doi: 10.1038/mt.2012.157. Epub 2012 Sep 18. Mol Ther. 2012. PMID: 22990673 Free PMC article.

5

Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury.

Tarlow BD, Finegold MJ, Grompe M. Tarlow BD, et al. Among authors: finegold mj. Hepatology. 2014 Jul;60(1):278-89. doi: 10.1002/hep.27084. Epub 2014 May 28. Hepatology. 2014. PMID: 24700457 Free PMC article.

6

In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery.

Held PK, Olivares EC, Aguilar CP, Finegold M, Calos MP, Grompe M. Held PK, et al. Mol Ther. 2005 Mar;11(3):399-408. doi: 10.1016/j.ymthe.2004.11.001. Mol Ther. 2005. PMID: 15727936 Free article.

7

A universal system to select gene-modified hepatocytes in vivo.

Nygaard S, Barzel A, Haft A, Major A, Finegold M, Kay MA, Grompe M. Nygaard S, et al. Sci Transl Med. 2016 Jun 8;8(342):342ra79. doi: 10.1126/scitranslmed.aad8166. Sci Transl Med. 2016. PMID: 27280686 Free PMC article.

8

In vivo correction of murine tyrosinemia type I by DNA-mediated transposition.

Montini E, Held PK, Noll M, Morcinek N, Al-Dhalimy M, Finegold M, Yant SR, Kay MA, Grompe M. Montini E, et al. Mol Ther. 2002 Dec;6(6):759-69. doi: 10.1006/mthe.2002.0812. Mol Ther. 2002. PMID: 12498772 Free article.

9

Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death.

Vogel A, van Den Berg IE, Al-Dhalimy M, Groopman J, Ou CN, Ryabinina O, Iordanov MS, Finegold M, Grompe M. Vogel A, et al. Hepatology. 2004 Feb;39(2):433-43. doi: 10.1002/hep.20077. Hepatology. 2004. PMID: 14767996

10

Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.

Overturf K, al-Dhalimy M, Ou CN, Finegold M, Tanguay R, Lieber A, Kay M, Grompe M. Overturf K, et al. Hum Gene Ther. 1997 Mar 20;8(5):513-21. doi: 10.1089/hum.1997.8.5-513. Hum Gene Ther. 1997. PMID: 9095403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters